Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This is a multicentric international phase III, double blind randomized study assessing
efficacy and safety in parallel group of BF2.649 (pitolisant) compared to placebo in add-on
to sodium oxybate of narcoleptic patients with residual Excessive Daytime Sleepiness (EDS)
during 8 weeks